Financial insights of VCYT

MyFinsight

For the quarter ending 2025-09-30, VCYT made $131,872K in revenue. $19,137K in net income. Net profit margin of 14.51%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Total revenue	131,872	130,164	114,473	115,860
Cost of revenue-Testing	33,777	32,407	-	-
Cost of revenue-Product	3,015	1,749	-	-
Cost of revenue	-	-	32,380	33,933
Cost of revenue-Biopharmaceutical And Other	1,091	3,572	-	-
Intangible asset amortization - cost of revenue	2,707	2,667	2,585	2,917
Total cost of revenue	40,590	40,395	34,965	36,850
Gross profit	91,282	89,769	79,508	79,010
Intangible asset amortization - operating expenses	-	-	622	880
Research and development	15,981	16,264	17,720	17,574
Impairment of long-lived assets	-	-	-	185
Selling and marketing	24,455	25,316	24,454	22,612
General and administrative	27,278	32,331	33,808	25,742
Impairment of assets	0	20,505	-	-
Intangible asset amortization - operating expenses-Intangible Asset Amortization	622	621	-	-
Total operating expenses	68,336	95,037	76,604	66,993
Income from operations	22,946	-5,268	2,904	12,017
Other income (loss), net	-4,057	6,518	4,524	4,831
Income before income taxes	18,889	1,250	7,428	16,848
Income tax (benefit) provision	-248	2,230	381	1,693
Net income	19,137	-980	7,047	15,155

Basic (in shares)	78,725,139	78,391,502	78,028,254	77,013,831
Basic (in usd per share)	0.24	-0.01	0.09	0.2
Diluted (in shares)	79,691,703	78,391,502	80,056,024	78,464,654
Diluted (in usd per share)	0.24	-0.01	0.09	0.19